Symbol="ARQT"
AssetType="Common Stock"
Name="Arcutis BiotherapeuticsÂ Inc"
Description="Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California."
CIK="1787306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2945 TOWNSGATE ROAD, SUITE 110, WESTLAKE VILLAGE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="579826000"
EBITDA="-314116992"
PERatio="None"
PEGRatio="None"
BookValue="2.277"
DividendPerShare="0"
DividendYield="0"
EPS="-5.65"
RevenuePerShareTTM="0.112"
ProfitMargin="0"
OperatingMarginTTM="-48.75"
ReturnOnAssetsTTM="-0.53"
ReturnOnEquityTTM="-1.663"
RevenueTTM="6467000"
GrossProfitTTM="2932000"
DilutedEPSTTM="-5.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="45.38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1385.79"
PriceToBookRatio="3.742"
EVToRevenue="1017.85"
EVToEBITDA="-2.448"
Beta="0.58"
num_52WeekHigh="27.4"
num_52WeekLow="7.25"
num_50DayMovingAverage="9.89"
num_200DayMovingAverage="14.22"
SharesOutstanding="61422000"
DividendDate="None"
ExDividendDate="None"
symbol="ARQT"
open="9.36"
high="9.59"
low="9.12"
price="9.44"
volume="589985.00"
latest_trading_day="2023-07-14"
previous_close="9.39"
change="0.05"
change_percent="0.5325%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1229940"
Change_recent_avg="-0.07"
Delta_recent_avg="0.78"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="-0.63"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_negative_thumbnail_id_2="142"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="1009"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_positive_thumbnail_id_2="960"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
